跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 81,802 条关于
“HIF-2 alpha”
全部
81,802
临床试验
57,084
药物
8,591
机构
1,434
资讯
14,693
2年前
FDA Approves Merck's Welireg for Advanced Kidney Cancer, Expanding Treatment Options
去年
China Approves MSD's Welireg (belzutifan) for VHL-Associated Tumors
去年
China Approves MSD's Welireg (belzutifan) for VHL Disease-Associated Tumors
去年
Exelixis and Merck Collaborate to Advance Zanzalintinib in Head and Neck and Renal Cell Carcinomas
去年
FDA Approves Belzutifan as First Oral Treatment for Advanced Pheochromocytoma and Paraganglioma
10个月前
Merck-Eisai Kidney Cancer Combination Shows Mixed Results in Phase 3 Trial
5个月前
Novel Dual HIF-1/2 Inhibitors Achieve Complete Tumor Remission in Combination with Immunotherapy
11个月前
Sanofi's Efdoralprin Alfa Achieves Primary Endpoints in Phase 2 Alpha-1 Antitrypsin Deficiency Study
11个月前
Risvodetinib Shows First-Ever Reduction in Alpha-Synuclein Pathology in Phase 2 Parkinson's Disease Trial
11个月前
Taiho Pharmaceutical Exercises Option for Casdatifan HIF-2α Inhibitor in Asia-Pacific Territories
第 1 页,共 1470 页
上一页
下一页